270 related articles for article (PubMed ID: 11113864)
1. Significantly different bcl-2 expression profiles in gastric and non-gastric primary extranodal high-grade B-cell lymphomas.
Cogliatti SB; Griesser H; Peng H; Du MQ; Isaacson PG; Zimmermann DR; Maibach RC; Schmid U
J Pathol; 2000 Dec; 192(4):470-8. PubMed ID: 11113864
[TBL] [Abstract][Full Text] [Related]
2. bcl-6 protein is identified in high-grade but not low-grade mucosa-associated lymphoid tissue lymphomas of the stomach.
Omonishi K; Yoshino T; Sakuma I; Kobayashi K; Moriyama M; Akagi T
Mod Pathol; 1998 Feb; 11(2):181-5. PubMed ID: 9504689
[TBL] [Abstract][Full Text] [Related]
3. Changes in Bcl-2 and p53 expression in recurrent B-cell lymphomas.
Ilyas M; Kendall M; Jalal H; Linton C; Rooney N
J Pathol; 1996 Nov; 180(3):249-53. PubMed ID: 8958800
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
5. Immunoreactivity for cyclin D3 is frequently detectable in high-grade primary gastric lymphomas in the absence of the t(6;14)(p21.1;q32.3) chromosomal translocation.
Pruneri G; Fabris S; Fasani R; Del Curto B; Capella C; Pozzi B; Motta T; Andreola S; Ferreri AJ; Ponzoni M; Viale G; Neri A
J Pathol; 2003 Aug; 200(5):596-601. PubMed ID: 12898595
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of the 5' noncoding region of the bcl-6 gene in primary gastric lymphomas.
Go JH; Yang WI; Ree HJ
Mod Pathol; 2001 May; 14(5):410-4. PubMed ID: 11353050
[TBL] [Abstract][Full Text] [Related]
7. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type.
Ott G; Katzenberger T; Greiner A; Kalla J; Rosenwald A; Heinrich U; Ott MM; Müller-Hermelink HK
Cancer Res; 1997 Sep; 57(18):3944-8. PubMed ID: 9307277
[TBL] [Abstract][Full Text] [Related]
8. Bcl-6 p53 mutations in lymphomas carrying the bcl-2/Jh rearrangement.
Bellido M; Capello D; Altés A; Estivill C; Gaidano G; Pujol R; Bordes R; Baiget M; Saglio G; Sierra J; Nomdedéu JF
Haematologica; 2002 Sep; 87(9):908-17. PubMed ID: 12217802
[TBL] [Abstract][Full Text] [Related]
9. An immunophenotypic and molecular study of primary large B-cell lymphoma of bone.
Huebner-Chan D; Fernandes B; Yang G; Lim MS
Mod Pathol; 2001 Oct; 14(10):1000-7. PubMed ID: 11598170
[TBL] [Abstract][Full Text] [Related]
10. Histopathologic features and expression of Bcl-2 and p53 proteins in primary gastric lymphomas.
Dogusoy G; Karayel FA; Göcener S; Göksel S
Pathol Oncol Res; 1999; 5(1):36-40. PubMed ID: 10079376
[TBL] [Abstract][Full Text] [Related]
11. Different bcl-2 protein expression in high-grade B-cell lymphomas derived from lymph node or mucosa-associated lymphoid tissue.
Villuendas R; Piris MA; Orradre JL; Mollejo M; Rodriguez R; Morente M
Am J Pathol; 1991 Nov; 139(5):989-93. PubMed ID: 1951637
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of CD95, P53, and BCL2 expression in extranodal non-Hodgkin's lymphoma.
Chatzitolios A; Venizelos I; Tripsiannis G; Anastassopoulos G; Papadopoulos N
Ann Hematol; 2010 Sep; 89(9):889-96. PubMed ID: 20352431
[TBL] [Abstract][Full Text] [Related]
13. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
[TBL] [Abstract][Full Text] [Related]
14. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
Zettl A; Rüdiger T; Marx A; Müller-Hermelink HK; Ott G
Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
[TBL] [Abstract][Full Text] [Related]
15. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas.
Kuo SH; Chen LT; Yeh KH; Wu MS; Hsu HC; Yeh PY; Mao TL; Chen CL; Doong SL; Lin JT; Cheng AL
J Clin Oncol; 2004 Sep; 22(17):3491-7. PubMed ID: 15337797
[TBL] [Abstract][Full Text] [Related]
16. [Cytogenetic and molecular aspects in MALT lymphomas].
Robledo M; Santos M; Santón A; Echezarreta G; Rivas C; Benítez J
Sangre (Barc); 1991 Aug; 36(4):295-9. PubMed ID: 1776108
[TBL] [Abstract][Full Text] [Related]
17. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia.
Lai R; Arber DA; Chang KL; Wilson CS; Weiss LM
Mod Pathol; 1998 Sep; 11(9):864-9. PubMed ID: 9758366
[TBL] [Abstract][Full Text] [Related]
18. Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia.
Kyokane K; Ito M; Sato Y; Ina K; Ando T; Kusugami K
J Pathol; 1998 Apr; 184(4):382-9. PubMed ID: 9664903
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic and immunohistochemical study of surgically treated primary gastric MALT lymphoma.
Insabato L; Di Vizio D; Tornillo L; D'Armiento FP; Siciliano A; Milo M; Palmieri G; Pettinato G; Terracciano LM
J Surg Oncol; 2003 Jun; 83(2):106-11. PubMed ID: 12772204
[TBL] [Abstract][Full Text] [Related]
20. Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype.
García-Sanz R; Vargas Montero M; Gonzalez Díaz M; del Carmen M; Santos C; Balanzategui Echevarria A; Flores Corral T; Hernández Martín JM; Caballero Barrigón MD; San Miguel JF
Haematologica; 1998 Mar; 83(3):209-16. PubMed ID: 9573674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
